Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/28488
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBioque, Miquel
dc.contributor.authorLlerena, Adrián
dc.contributor.authorCabrera, Bibiana
dc.contributor.authorMezquida, Gisela
dc.contributor.authorLobo, Antonio
dc.contributor.authorGonzález-Pinto, Ana
dc.contributor.authorDíaz-Caneja, Covadonga M
dc.contributor.authorCorripio, Iluminada
dc.contributor.authorAguilar, Eduardo J
dc.contributor.authorBulbena, Antoni
dc.contributor.authorCastro-Fornieles, Josefina
dc.contributor.authorVieta, Eduard
dc.contributor.authorLafuente, Amàlia
dc.contributor.authorMas, Sergi
dc.contributor.authorParellada, Mara
dc.contributor.authorSaiz-Ruiz, Jerónimo
dc.contributor.authorCuesta, Manuel J
dc.contributor.authorBernardo, Miguel
dc.date.accessioned2019-06-28T15:34:13Z-
dc.date.available2019-06-28T15:34:13Z-
dc.date.issued2016-04
dc.identifier.citationInt. J. Neuropsychopharmacol..2016 Apr;(19)4:
dc.identifier.urihttps://hdl.handle.net/20.500.12530/28488-
dc.description.abstractThe characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice.
dc.language.isoeng
dc.rightsopenAccess-
dc.subjectAntipsychotic
dc.subjectfirst episode psychosis
dc.subjectpharmacovigilance
dc.subjectpolytherapy
dc.subjectpsychotropic drugs
dc.subjectschizophrenia.
dc.subject.meshAcute Disease
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAntipsychotic Agents
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLogistic Models
dc.subject.meshMale
dc.subject.meshPharmacovigilance
dc.subject.meshPolypharmacy
dc.subject.meshPsychiatric Status Rating Scales
dc.subject.meshPsychotic Disorders
dc.subject.meshSex Factors
dc.subject.meshSpain
dc.subject.meshTreatment Outcome
dc.subject.meshYoung Adult
dc.titleA Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
dc.typeArtículo
dc.identifier.pubmedID26506856
dc.format.volume19
dc.identifier.e-issn1469-5111
dc.identifier.journalThe international journal of neuropsychopharmacology
dc.identifier.doi10.1093/ijnp/pyv121
dc.format.number4
dc.identifier.pmcPMC4851267
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeResearch Support, Non-U.S. Gov't
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC4851267.pdf659.79 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.